![GSK, Novartis top Access to Medicine ranking with pricing, R&D initiatives | S&P Global Market Intelligence GSK, Novartis top Access to Medicine ranking with pricing, R&D initiatives | S&P Global Market Intelligence](https://www.snl.com/articles/395847134.png)
GSK, Novartis top Access to Medicine ranking with pricing, R&D initiatives | S&P Global Market Intelligence
![GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_101380_a53786a6-9ceb-48f2-8411-276c2e1b6478_0.png)
GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
![Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData - Express Pharma Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData - Express Pharma](https://cdn.expresspharma.in/wp-content/uploads/2023/08/22151252/PR18116.jpg)
Top 20 global biopharma companies report 2.3 per cent market cap growth in Q2 2023: GlobalData - Express Pharma
![GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_101379_2e746a63-4a5f-4c53-a839-000a1e75a721_0.png)
GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
![Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_152867_e4c0333c-75ea-4f1c-980f-89a5fd811bc4_0.png)
Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData
![Proclinical on X: "We've compiled a list of the top 10 pharmaceutical companies in the world right now - which have made the cut? #top10pharma # pharma https://t.co/d8va9zgyEN https://t.co/ZlLwDV19gD" / X Proclinical on X: "We've compiled a list of the top 10 pharmaceutical companies in the world right now - which have made the cut? #top10pharma # pharma https://t.co/d8va9zgyEN https://t.co/ZlLwDV19gD" / X](https://pbs.twimg.com/media/D2HdKvyWoAE4P1i.jpg:large)
Proclinical on X: "We've compiled a list of the top 10 pharmaceutical companies in the world right now - which have made the cut? #top10pharma # pharma https://t.co/d8va9zgyEN https://t.co/ZlLwDV19gD" / X
![Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/05/top-20-biopharma-image.png)
Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology
Invictus Finserv LLP - Indian Pharma companies are major global players in the generic space. 8 of the top 20 generic manufacturers in the world are Indian, with cost of manufacturing appx
![Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology Top 20 biopharmaceutical companies hold their spot despite market cap drop in Q1 2022 - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/05/top-20-biopharma-image-150x150.png)